Page last updated: 2024-10-30

kojic acid and Injury, Myocardial Reperfusion

kojic acid has been researched along with Injury, Myocardial Reperfusion in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The treatment with catechol, mimosine, or deferoxamine reduced the maximum intensity of DMPO-OH signal to about one third of control."1.28Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts. ( Abe, T; Akita, T; Kamiya, K; Katoh, S; Kodama, I; Toyama, J, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katoh, S1
Toyama, J1
Kodama, I1
Kamiya, K1
Akita, T1
Abe, T1
van der Kraaij, AM1
van Eijk, HG1
Koster, JF1

Other Studies

2 other studies available for kojic acid and Injury, Myocardial Reperfusion

ArticleYear
Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1992, Volume: 24, Issue:6

    Topics: Animals; Animals, Newborn; Catechols; Creatine Kinase; Deferoxamine; Electron Spin Resonance Spectro

1992
Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3.
    Circulation, 1989, Volume: 80, Issue:1

    Topics: Animals; Antioxidants; Catechin; Chemical Phenomena; Chemistry; Coronary Circulation; Deferiprone; I

1989